ID   TYK2_HUMAN              Reviewed;        1187 AA.
AC   P29597; Q6QB10; Q96CH0;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 3.
DT   10-MAY-2017, entry version 189.
DE   RecName: Full=Non-receptor tyrosine-protein kinase TYK2;
DE            EC=2.7.10.2;
GN   Name=TYK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PHE-362 AND SER-684.
RX   PubMed=2216457;
RA   Firmbach-Kraft I., Byers M., Shows T., Dalla-Favera R.,
RA   Krolewski J.J.;
RT   "TYK2, prototype of a novel class of non-receptor tyrosine kinase
RT   genes.";
RL   Oncogene 5:1329-1336(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-4; HIS-197;
RP   PHE-362; SER-363 AND SER-684.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 289-1187.
RX   PubMed=1386289; DOI=10.1016/0092-8674(92)90105-L;
RA   Velazquez L., Fellous M., Stark G.R., Pellegrini S.;
RT   "A protein tyrosine kinase in the interferon alpha/beta signaling
RT   pathway.";
RL   Cell 70:313-322(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1007-1162, AND TISSUE SPECIFICITY.
RX   PubMed=2156206;
RA   Krolewski J.J., Lee R., Eddy R., Shows T.B., Dalla-Favera R.;
RT   "Identification and chromosomal mapping of new human tyrosine kinase
RT   genes.";
RL   Oncogene 5:277-282(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1025-1082.
RX   PubMed=2247464; DOI=10.1073/pnas.87.22.8913;
RA   Partanen J., Maekelae T.P., Alitalo R., Lehvaeslaiho H., Alitalo K.;
RT   "Putative tyrosine kinases expressed in K-562 human leukemia cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8913-8917(1990).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF IFNAR1.
RX   PubMed=7526154; DOI=10.1128/MCB.14.12.8133;
RA   Colamonici O., Yan H., Domanski P., Handa R., Smalley D.,
RA   Mullersman J., Witte M., Krishnan K., Krolewski J.;
RT   "Direct binding to and tyrosine phosphorylation of the alpha subunit
RT   of the type I interferon receptor by p135tyk2 tyrosine kinase.";
RL   Mol. Cell. Biol. 14:8133-8142(1994).
RN   [8]
RP   INTERACTION WITH JAKMIP1.
RX   PubMed=15277531; DOI=10.1074/jbc.M401915200;
RA   Steindler C., Li Z., Algarte M., Alcover A., Libri V., Ragimbeau J.,
RA   Pellegrini S.;
RT   "Jamip1 (marlin-1) defines a family of proteins interacting with Janus
RT   kinases and microtubules.";
RL   J. Biol. Chem. 279:43168-43177(2004).
RN   [9]
RP   INVOLVEMENT IN IMD35.
RX   PubMed=17088085; DOI=10.1016/j.immuni.2006.09.009;
RA   Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K.,
RA   Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., Kaneko H.,
RA   Kondo N., Tsuge I., Yachie A., Sakiyama Y., Iwata T., Bessho F.,
RA   Ohishi T., Joh K., Imai K., Kogawa K., Shinohara M., Fujieda M.,
RA   Wakiguchi H., Pasic S., Abinun M., Ochs H.D., Renner E.D., Jansson A.,
RA   Belohradsky B.H., Metin A., Shimizu N., Mizutani S., Miyawaki T.,
RA   Nonoyama S., Karasuyama H.;
RT   "Human tyrosine kinase 2 deficiency reveals its requisite roles in
RT   multiple cytokine signals involved in innate and acquired immunity.";
RL   Immunity 25:745-755(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292 AND SER-884, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292 AND SER-884, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292 AND SER-499, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 888-1182 IN COMPLEX WITH
RP   INHIBITOR, AND PHOSPHORYLATION AT TYR-1054.
RX   PubMed=20478313; DOI=10.1016/j.jmb.2010.05.020;
RA   Chrencik J.E., Patny A., Leung I.K., Korniski B., Emmons T.L.,
RA   Hall T., Weinberg R.A., Gormley J.A., Williams J.M., Day J.E.,
RA   Hirsch J.L., Kiefer J.R., Leone J.W., Fischer H.D., Sommers C.D.,
RA   Huang H.C., Jacobsen E.J., Tenbrink R.E., Tomasselli A.G.,
RA   Benson T.E.;
RT   "Structural and thermodynamic characterization of the TYK2 and JAK3
RT   kinase domains in complex with CP-690550 and CMP-6.";
RL   J. Mol. Biol. 400:413-433(2010).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-362; SER-363; MET-386; SER-684;
RP   TRP-703; ARG-732; VAL-928; ALA-1104 AND GLY-1163.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probably involved in intracellular signal transduction
CC       by being involved in the initiation of type I IFN signaling.
CC       Phosphorylates the interferon-alpha/beta receptor alpha chain.
CC       {ECO:0000269|PubMed:7526154}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Interacts with JAKMIP1. {ECO:0000269|PubMed:15277531,
CC       ECO:0000269|PubMed:20478313}.
CC   -!- INTERACTION:
CC       Q13643:FHL3; NbExp=5; IntAct=EBI-1383454, EBI-741101;
CC       Q6IBN1:HNRPK; NbExp=3; IntAct=EBI-1383454, EBI-3440248;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1383454, EBI-352572;
CC       Q5VWX1:KHDRBS2; NbExp=6; IntAct=EBI-1383454, EBI-742808;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-1383454, EBI-10171697;
CC       Q9BUZ4:TRAF4; NbExp=3; IntAct=EBI-1383454, EBI-3650647;
CC   -!- TISSUE SPECIFICITY: Observed in all cell lines analyzed. Expressed
CC       in a variety of lymphoid and non-lymphoid cell lines.
CC       {ECO:0000269|PubMed:2156206}.
CC   -!- DOMAIN: The FERM domain mediates interaction with JAKMIP1.
CC   -!- DISEASE: Immunodeficiency 35 (IMD35) [MIM:611521]: A primary
CC       immunodeficiency characterized by recurrent skin abscesses,
CC       pneumonia, and highly elevated serum IgE.
CC       {ECO:0000269|PubMed:17088085}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=TYK2base; Note=TYK2 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/TYK2base/";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/tyk2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54637; CAA38449.1; -; mRNA.
DR   EMBL; AY549314; AAS37680.1; -; Genomic_DNA.
DR   EMBL; BC014243; AAH14243.1; -; mRNA.
DR   CCDS; CCDS12236.1; -.
DR   PIR; S12127; TVHUY2.
DR   RefSeq; NP_003322.3; NM_003331.4.
DR   RefSeq; XP_011526547.1; XM_011528245.1.
DR   UniGene; Hs.75516; -.
DR   PDB; 3LXN; X-ray; 2.50 A; A=888-1182.
DR   PDB; 3LXP; X-ray; 1.65 A; A=888-1182.
DR   PDB; 3NYX; X-ray; 2.50 A; A=885-1176.
DR   PDB; 3NZ0; X-ray; 2.00 A; A=885-1176.
DR   PDB; 3ZON; X-ray; 2.15 A; A=541-873.
DR   PDB; 4GFO; X-ray; 2.30 A; A=884-1176.
DR   PDB; 4GIH; X-ray; 2.00 A; A=885-1176.
DR   PDB; 4GII; X-ray; 2.31 A; A=885-1176.
DR   PDB; 4GJ2; X-ray; 2.40 A; A=885-1176.
DR   PDB; 4GJ3; X-ray; 2.50 A; A=885-1176.
DR   PDB; 4GVJ; X-ray; 2.03 A; A=885-1176.
DR   PDB; 4OLI; X-ray; 2.80 A; A=566-1187.
DR   PDB; 4PO6; X-ray; 1.99 A; A=23-583.
DR   PDB; 4PY1; X-ray; 2.16 A; A=888-1182.
DR   PDB; 4WOV; X-ray; 1.80 A; A/B=575-869.
DR   PDB; 5C01; X-ray; 2.15 A; A/B=556-871.
DR   PDB; 5C03; X-ray; 1.90 A; A/B=556-871.
DR   PDB; 5F1Z; X-ray; 2.65 A; A=884-1176.
DR   PDB; 5F20; X-ray; 2.91 A; A=884-1176.
DR   PDB; 5TKD; X-ray; 1.92 A; A/B=575-869.
DR   PDBsum; 3LXN; -.
DR   PDBsum; 3LXP; -.
DR   PDBsum; 3NYX; -.
DR   PDBsum; 3NZ0; -.
DR   PDBsum; 3ZON; -.
DR   PDBsum; 4GFO; -.
DR   PDBsum; 4GIH; -.
DR   PDBsum; 4GII; -.
DR   PDBsum; 4GJ2; -.
DR   PDBsum; 4GJ3; -.
DR   PDBsum; 4GVJ; -.
DR   PDBsum; 4OLI; -.
DR   PDBsum; 4PO6; -.
DR   PDBsum; 4PY1; -.
DR   PDBsum; 4WOV; -.
DR   PDBsum; 5C01; -.
DR   PDBsum; 5C03; -.
DR   PDBsum; 5F1Z; -.
DR   PDBsum; 5F20; -.
DR   PDBsum; 5TKD; -.
DR   ProteinModelPortal; P29597; -.
DR   SMR; P29597; -.
DR   BioGrid; 113148; 91.
DR   DIP; DIP-1062N; -.
DR   IntAct; P29597; 44.
DR   MINT; MINT-107878; -.
DR   STRING; 9606.ENSP00000264818; -.
DR   BindingDB; P29597; -.
DR   ChEMBL; CHEMBL3553; -.
DR   GuidetoPHARMACOLOGY; 2269; -.
DR   iPTMnet; P29597; -.
DR   PhosphoSitePlus; P29597; -.
DR   BioMuta; TYK2; -.
DR   DMDM; 56405328; -.
DR   EPD; P29597; -.
DR   MaxQB; P29597; -.
DR   PaxDb; P29597; -.
DR   PeptideAtlas; P29597; -.
DR   PRIDE; P29597; -.
DR   DNASU; 7297; -.
DR   Ensembl; ENST00000264818; ENSP00000264818; ENSG00000105397.
DR   Ensembl; ENST00000525621; ENSP00000431885; ENSG00000105397.
DR   GeneID; 7297; -.
DR   KEGG; hsa:7297; -.
DR   UCSC; uc002moc.5; human.
DR   CTD; 7297; -.
DR   DisGeNET; 7297; -.
DR   GeneCards; TYK2; -.
DR   H-InvDB; HIX0202831; -.
DR   HGNC; HGNC:12440; TYK2.
DR   HPA; HPA005157; -.
DR   MalaCards; TYK2; -.
DR   MIM; 176941; gene.
DR   MIM; 611521; phenotype.
DR   neXtProt; NX_P29597; -.
DR   OpenTargets; ENSG00000105397; -.
DR   Orphanet; 331226; Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency.
DR   Orphanet; 85408; Juvenile rheumatoid factor-negative polyarthritis.
DR   Orphanet; 85410; Oligoarticular juvenile arthritis.
DR   PharmGKB; PA37094; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118799; -.
DR   HOGENOM; HOG000049158; -.
DR   HOVERGEN; HBG006195; -.
DR   InParanoid; P29597; -.
DR   KO; K11219; -.
DR   OMA; FCDFQDI; -.
DR   OrthoDB; EOG091G01IS; -.
DR   PhylomeDB; P29597; -.
DR   TreeFam; TF327041; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1059683; Interleukin-6 signaling.
DR   Reactome; R-HSA-110056; MAPK3 (ERK1) activation.
DR   Reactome; R-HSA-112411; MAPK1 (ERK2) activation.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6788467; IL-6-type cytokine receptor ligand interactions.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-912694; Regulation of IFNA signaling.
DR   SignaLink; P29597; -.
DR   SIGNOR; P29597; -.
DR   ChiTaRS; TYK2; human.
DR   EvolutionaryTrace; P29597; -.
DR   GeneWiki; Tyrosine_kinase_2; -.
DR   GenomeRNAi; 7297; -.
DR   PRO; PR:P29597; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105397; -.
DR   CleanEx; HS_TYK2; -.
DR   ExpressionAtlas; P29597; baseline and differential.
DR   Genevisible; P29597; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005131; F:growth hormone receptor binding; IPI:BHF-UCL.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome.
DR   GO; GO:0031702; F:type 1 angiotensin receptor binding; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR016045; Tyr_kinase_non-rcpt_TYK2_N.
DR   Pfam; PF07714; Pkinase_Tyr; 2.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR00109; TYRKINASE.
DR   PRINTS; PR01827; YKINASETYK2.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; SH2 domain; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1   1187       Non-receptor tyrosine-protein kinase
FT                                TYK2.
FT                                /FTId=PRO_0000088177.
FT   DOMAIN       26    431       FERM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00084}.
FT   DOMAIN      450    529       SH2; atypical.
FT   DOMAIN      589    875       Protein kinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      897   1176       Protein kinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     903    911       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE   1023   1023       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     930    930       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     292    292       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     499    499       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     525    525       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R117}.
FT   MOD_RES     604    604       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9R117}.
FT   MOD_RES     884    884       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES    1054   1054       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20478313}.
FT   VARIANT       4      4       R -> C (in dbSNP:rs35163004).
FT                                /FTId=VAR_037796.
FT   VARIANT       4      4       R -> H (in dbSNP:rs12720343).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020597.
FT   VARIANT      81     81       A -> V (in dbSNP:rs1049619).
FT                                /FTId=VAR_037797.
FT   VARIANT     197    197       R -> H (in dbSNP:rs12720263).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020598.
FT   VARIANT     362    362       V -> F (in dbSNP:rs2304256).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2216457,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020599.
FT   VARIANT     363    363       G -> S (in dbSNP:rs2304255).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020600.
FT   VARIANT     386    386       V -> M (in dbSNP:rs55956017).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041870.
FT   VARIANT     442    442       R -> Q (in dbSNP:rs2304254).
FT                                /FTId=VAR_037798.
FT   VARIANT     684    684       I -> S (in dbSNP:rs12720356).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2216457,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_020286.
FT   VARIANT     703    703       R -> W (in dbSNP:rs55882956).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041871.
FT   VARIANT     732    732       H -> R (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041872.
FT   VARIANT     820    820       P -> H (in dbSNP:rs34046749).
FT                                /FTId=VAR_037799.
FT   VARIANT     928    928       A -> V (in dbSNP:rs35018800).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041873.
FT   VARIANT    1104   1104       P -> A (in dbSNP:rs34536443).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041874.
FT   VARIANT    1163   1163       E -> G (in dbSNP:rs55886939).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041875.
FT   CONFLICT    869    869       L -> V (in Ref. 1; CAA38449).
FT                                {ECO:0000305}.
FT   CONFLICT    882    882       P -> R (in Ref. 1; CAA38449).
FT                                {ECO:0000305}.
FT   CONFLICT    887    888       SD -> VG (in Ref. 1; CAA38449).
FT                                {ECO:0000305}.
FT   CONFLICT    891    891       V -> T (in Ref. 1; CAA38449).
FT                                {ECO:0000305}.
FT   CONFLICT   1016   1016       A -> S (in Ref. 3; AAH14243).
FT                                {ECO:0000305}.
FT   CONFLICT   1017   1018       QH -> HD (in Ref. 1; CAA38449).
FT                                {ECO:0000305}.
FT   STRAND       28     31       {ECO:0000244|PDB:4PO6}.
FT   STRAND       42     46       {ECO:0000244|PDB:4PO6}.
FT   STRAND       49     52       {ECO:0000244|PDB:4PO6}.
FT   HELIX        53     64       {ECO:0000244|PDB:4PO6}.
FT   HELIX        68     73       {ECO:0000244|PDB:4PO6}.
FT   STRAND       74     78       {ECO:0000244|PDB:4PO6}.
FT   TURN         79     82       {ECO:0000244|PDB:4PO6}.
FT   STRAND       83     85       {ECO:0000244|PDB:4PO6}.
FT   STRAND       90     92       {ECO:0000244|PDB:4PO6}.
FT   TURN         93     98       {ECO:0000244|PDB:4PO6}.
FT   STRAND      101    105       {ECO:0000244|PDB:4PO6}.
FT   TURN        110    113       {ECO:0000244|PDB:4PO6}.
FT   STRAND      122    124       {ECO:0000244|PDB:4PO6}.
FT   HELIX       146    161       {ECO:0000244|PDB:4PO6}.
FT   HELIX       167    169       {ECO:0000244|PDB:4PO6}.
FT   HELIX       173    198       {ECO:0000244|PDB:4PO6}.
FT   HELIX       202    208       {ECO:0000244|PDB:4PO6}.
FT   HELIX       211    213       {ECO:0000244|PDB:4PO6}.
FT   HELIX       217    225       {ECO:0000244|PDB:4PO6}.
FT   HELIX       228    243       {ECO:0000244|PDB:4PO6}.
FT   HELIX       252    266       {ECO:0000244|PDB:4PO6}.
FT   TURN        268    271       {ECO:0000244|PDB:4PO6}.
FT   STRAND      273    284       {ECO:0000244|PDB:4PO6}.
FT   HELIX       285    287       {ECO:0000244|PDB:4PO6}.
FT   STRAND      314    319       {ECO:0000244|PDB:4PO6}.
FT   TURN        320    322       {ECO:0000244|PDB:4PO6}.
FT   STRAND      323    328       {ECO:0000244|PDB:4PO6}.
FT   STRAND      375    378       {ECO:0000244|PDB:4PO6}.
FT   HELIX       380    382       {ECO:0000244|PDB:4PO6}.
FT   STRAND      383    389       {ECO:0000244|PDB:4PO6}.
FT   STRAND      392    397       {ECO:0000244|PDB:4PO6}.
FT   STRAND      400    406       {ECO:0000244|PDB:4PO6}.
FT   HELIX       410    427       {ECO:0000244|PDB:4PO6}.
FT   HELIX       436    438       {ECO:0000244|PDB:4PO6}.
FT   HELIX       441    449       {ECO:0000244|PDB:4PO6}.
FT   HELIX       457    464       {ECO:0000244|PDB:4PO6}.
FT   STRAND      470    475       {ECO:0000244|PDB:4PO6}.
FT   STRAND      483    492       {ECO:0000244|PDB:4PO6}.
FT   STRAND      498    508       {ECO:0000244|PDB:4PO6}.
FT   STRAND      514    516       {ECO:0000244|PDB:4PO6}.
FT   STRAND      523    525       {ECO:0000244|PDB:4PO6}.
FT   HELIX       526    533       {ECO:0000244|PDB:4PO6}.
FT   STRAND      537    540       {ECO:0000244|PDB:4PO6}.
FT   STRAND      543    546       {ECO:0000244|PDB:4PO6}.
FT   STRAND      562    565       {ECO:0000244|PDB:4PO6}.
FT   HELIX       586    588       {ECO:0000244|PDB:4WOV}.
FT   STRAND      589    598       {ECO:0000244|PDB:4WOV}.
FT   STRAND      601    608       {ECO:0000244|PDB:4WOV}.
FT   STRAND      637    644       {ECO:0000244|PDB:4WOV}.
FT   HELIX       649    663       {ECO:0000244|PDB:4WOV}.
FT   STRAND      673    679       {ECO:0000244|PDB:4WOV}.
FT   STRAND      682    688       {ECO:0000244|PDB:4WOV}.
FT   HELIX       695    701       {ECO:0000244|PDB:4WOV}.
FT   TURN        702    704       {ECO:0000244|PDB:4WOV}.
FT   HELIX       708    727       {ECO:0000244|PDB:4WOV}.
FT   HELIX       737    739       {ECO:0000244|PDB:4WOV}.
FT   STRAND      740    744       {ECO:0000244|PDB:4WOV}.
FT   STRAND      754    757       {ECO:0000244|PDB:4WOV}.
FT   HELIX       764    766       {ECO:0000244|PDB:4WOV}.
FT   HELIX       769    774       {ECO:0000244|PDB:4WOV}.
FT   TURN        775    778       {ECO:0000244|PDB:4WOV}.
FT   HELIX       781    783       {ECO:0000244|PDB:4WOV}.
FT   HELIX       795    808       {ECO:0000244|PDB:4WOV}.
FT   TURN        809    811       {ECO:0000244|PDB:4WOV}.
FT   TURN        814    817       {ECO:0000244|PDB:4WOV}.
FT   HELIX       820    828       {ECO:0000244|PDB:4WOV}.
FT   HELIX       839    841       {ECO:0000244|PDB:4WOV}.
FT   HELIX       842    848       {ECO:0000244|PDB:4WOV}.
FT   HELIX       853    855       {ECO:0000244|PDB:4WOV}.
FT   HELIX       859    867       {ECO:0000244|PDB:4WOV}.
FT   HELIX       894    896       {ECO:0000244|PDB:3LXP}.
FT   STRAND      897    905       {ECO:0000244|PDB:3LXP}.
FT   STRAND      907    916       {ECO:0000244|PDB:3LXP}.
FT   STRAND      920    922       {ECO:0000244|PDB:3NZ0}.
FT   STRAND      925    932       {ECO:0000244|PDB:3LXP}.
FT   HELIX       938    953       {ECO:0000244|PDB:3LXP}.
FT   STRAND      962    968       {ECO:0000244|PDB:3LXP}.
FT   TURN        969    972       {ECO:0000244|PDB:3LXP}.
FT   STRAND      973    978       {ECO:0000244|PDB:3LXP}.
FT   HELIX       986    989       {ECO:0000244|PDB:3LXP}.
FT   HELIX       990    992       {ECO:0000244|PDB:3LXP}.
FT   HELIX       997   1016       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1026   1028       {ECO:0000244|PDB:3LXP}.
FT   STRAND     1029   1031       {ECO:0000244|PDB:3LXP}.
FT   STRAND     1037   1039       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1042   1044       {ECO:0000244|PDB:3LXP}.
FT   STRAND     1053   1056       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1065   1067       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1070   1075       {ECO:0000244|PDB:3LXP}.
FT   STRAND     1077   1079       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1080   1095       {ECO:0000244|PDB:3LXP}.
FT   TURN       1096   1098       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1100   1102       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1104   1112       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1117   1129       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1142   1151       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1156   1158       {ECO:0000244|PDB:3LXP}.
FT   HELIX      1162   1177       {ECO:0000244|PDB:3LXP}.
SQ   SEQUENCE   1187 AA;  133650 MW;  F76C25D6A919EDBC CRC64;
     MPLRHWGMAR GSKPVGDGAQ PMAAMGGLKV LLHWAGPGGG EPWVTFSESS LTAEEVCIHI
     AHKVGITPPC FNLFALFDAQ AQVWLPPNHI LEIPRDASLM LYFRIRFYFR NWHGMNPREP
     AVYRCGPPGT EASSDQTAQG MQLLDPASFE YLFEQGKHEF VNDVASLWEL STEEEIHHFK
     NESLGMAFLH LCHLALRHGI PLEEVAKKTS FKDCIPRSFR RHIRQHSALT RLRLRNVFRR
     FLRDFQPGRL SQQMVMVKYL ATLERLAPRF GTERVPVCHL RLLAQAEGEP CYIRDSGVAP
     TDPGPESAAG PPTHEVLVTG TGGIQWWPVE EEVNKEEGSS GSSGRNPQAS LFGKKAKAHK
     AVGQPADRPR EPLWAYFCDF RDITHVVLKE HCVSIHRQDN KCLELSLPSR AAALSFVSLV
     DGYFRLTADS SHYLCHEVAP PRLVMSIRDG IHGPLLEPFV QAKLRPEDGL YLIHWSTSHP
     YRLILTVAQR SQAPDGMQSL RLRKFPIEQQ DGAFVLEGWG RSFPSVRELG AALQGCLLRA
     GDDCFSLRRC CLPQPGETSN LIIMRGARAS PRTLNLSQLS FHRVDQKEIT QLSHLGQGTR
     TNVYEGRLRV EGSGDPEEGK MDDEDPLVPG RDRGQELRVV LKVLDPSHHD IALAFYETAS
     LMSQVSHTHL AFVHGVCVRG PENIMVTEYV EHGPLDVWLR RERGHVPMAW KMVVAQQLAS
     ALSYLENKNL VHGNVCGRNI LLARLGLAEG TSPFIKLSDP GVGLGALSRE ERVERIPWLA
     PECLPGGANS LSTAMDKWGF GATLLEICFD GEAPLQSRSP SEKEHFYQRQ HRLPEPSCPQ
     LATLTSQCLT YEPTQRPSFR TILRDLTRLQ PHNLADVLTV NPDSPASDPT VFHKRYLKKI
     RDLGEGHFGK VSLYCYDPTN DGTGEMVAVK ALKADCGPQH RSGWKQEIDI LRTLYHEHII
     KYKGCCEDQG EKSLQLVMEY VPLGSLRDYL PRHSIGLAQL LLFAQQICEG MAYLHAQHYI
     HRDLAARNVL LDNDRLVKIG DFGLAKAVPE GHEYYRVRED GDSPVFWYAP ECLKEYKFYY
     ASDVWSFGVT LYELLTHCDS SQSPPTKFLE LIGIAQGQMT VLRLTELLER GERLPRPDKC
     PCEVYHLMKN CWETEASFRP TFENLIPILK TVHEKYQGQA PSVFSVC
//
